fluorocholine

1.	Kwee, Sandi A: 4 articles (01/2008 - 07/2004)
2.	Coel, Marc N: 4 articles (01/2008 - 07/2004)
3.	Langsteger, Werner: 3 articles (10/2008 - 11/2006)
4.	Pahnke, Jens: 3 articles (04/2007 - 11/2004)
5.	Spaeth, Nicolas: 3 articles (04/2007 - 11/2004)
6.	Weber, Bruno: 3 articles (04/2007 - 11/2004)
7.	Buck, Alfred: 3 articles (04/2007 - 11/2004)
8.	Wyss, Matthias T: 3 articles (04/2007 - 11/2004)
9.	Westera, Gerrit: 3 articles (06/2006 - 11/2004)
10.	Beheshti, Mohsen: 2 articles (10/2008 - 08/2007)

Related Diseases

1.	Prostatic Neoplasms (Prostate Cancer) 05/01/2008 - "RECENT FINDINGS: Prostate cancer: PET imaging with the new radiotracers 11C-choline, 18F-fluorocholine, and 11C-acetate show promising results" 01/01/2008 - "Fluorocholine PET can serve to localize dominant areas of malignancy in patients with prostate cancer" 01/01/2008 - "Use of step-section histopathology to evaluate 18F-fluorocholine PET sextant localization of prostate cancer." 12/01/2006 - "18)F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients." 02/01/2006 - "Localization of primary prostate cancer with dual-phase 18F-fluorocholine PET." Get all the results and reference details, order at left...
2.	Neoplasms (Cancer) 01/01/2008 - "PURPOSE: The aim of this study was to investigate (a) in vitro the relationship between [(18)F]fluorocholine ([(18)F]FCH) uptake and cell growth in endocrine cell lines and (b) in vivo the uptake of [(18)F]FCH by tumoral sites in an animal model of metastasized endocrine tumor" 01/01/2008 - "In vitro and in vivo studies with [(18)F]fluorocholine on digestive tumoral cell lines and in an animal model of metastasized endocrine tumor." 01/01/2008 - "To assess positron emission tomography (PET) with fluorine-18 fluorocholine for sextant localization of malignant prostate tumors" 01/01/2002 - "METHODS: The biodistribution of 18F-FCH was obtained at time points up to 10 h after administration in control and tumor-bearing anesthetized nude mice" 06/01/2008 - "PURPOSE: [(18)F]Fluorocholine ([(18)F]FCH) was developed as an analog of [(11)C]choline for tumor imaging; however, its metabolic handling remains ill defined" Get all the results and reference details, order at left...
3.	Neoplasm Metastasis (Metastasis) 11/01/2006 - "The largest lymph node metastasis not seen with [18F]fluorocholine combined in-line positron emission tomography-computerized tomography was 8 mm. Laparoscopic sentinel guided lymph node dissection revealed lymph node metastases in 8 of 10 patients" 08/01/2007 - "18F]fluorocholine PET/CT in the assessment of bone metastases in prostate cancer." 08/01/2007 - "CONCLUSION: High-grade gliomas, metastases, and benign lesions can be distinguished on the basis of measured fluorocholine uptake" 11/01/2006 - "18F]fluorocholine combined in-line positron emission tomography-computerized tomography is not useful in searching for occult lymph node metastases in clinically localized prostate cancer" 11/01/2006 - "We investigated whether preoperative [18F]fluorocholine combined in-line positron emission tomography-computerized tomography and intraoperative laparoscopic radioisotope guided sentinel pelvic lymph node dissection can detect pelvic lymph node metastases in patients with clinically localized prostate cancer as reliably as extended pelvic lymph node dissection" Get all the results and reference details, order at left...
4.	Glioma (Gliomas) 06/01/2008 - "Biodisposition and metabolism of [(18)F]fluorocholine in 9L glioma cells and 9L glioma-bearing fisher rats." 08/01/2007 - "Increased peritumoral fluorocholine uptake is a distinguishing characteristic of high-grade gliomas." 07/01/2004 - "METHODS: Brain positron emission tomography (PET) imaging with F-18 fluorocholine (FCH) was performed on 2 patients with intracranial lesions suspected to be high-grade malignant gliomas on the basis of magnetic resonance (MR) imaging and multivoxel 1H-MR spectroscopic imaging (MRSI) findings" 08/01/2007 - "CONCLUSION: High-grade gliomas, metastases, and benign lesions can be distinguished on the basis of measured fluorocholine uptake" 06/01/2006 - "Uptake of 18F-fluorocholine, 18F-fluoro-ethyl-L: -tyrosine and 18F-fluoro-2-deoxyglucose in F98 gliomas in the rat." Get all the results and reference details, order at left...
5.	Lithiasis 02/01/2007 - "Asymmetric F-18 fluorocholine uptake of submaxillary glands revealing intraglandular lithiasis." Get all the results and reference details, order at left...
12 Diseases and 24 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Choline (Choline Chloride)
2.	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
3.	Fluorine
4.	Tyrosine (L-Tyrosine)
5.	Fluorides
6.	DNA (Deoxyribonucleic Acid)
7.	SIP(L19) fusion protein
8.	FRP-170
9.	2'-fluoro-5-methylarabinosyluracil (Clevudine)
10.	Ro 07-0741
10 Drugs and Important Bio-Agents and 10 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Lymph Node Excision (Lymph Node Dissection)
2.	General Anesthesia
3.	Aftercare (After-Treatment)
3 Therapies and Procedures and 3 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>